A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26679 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Philippe Bareille und 6 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Stevenage, UK. Hauptthemen laut MEDLINE: Bronchodilator Agents, Asthma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GSK.
Abstract (Originalsprache)
Introduction : Growth impairment is a known adverse event (AE) of corticosteroids in children. This study aimed to assess the effect of once‐daily (QD) inhaled fluticasone furoate (FF) versus placebo on growth velocity over 1 year in prepubertal children with well‐controlled asthma. Materials and Methods : This randomized, double‐blind, parallel‐group, placebo‐controlled, multicenter study (NCT02889809) included prepubertal children, aged 5 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GSK, Stevenage, UK.
- GSK, Brentford, London, UK.
- Alergo-Med Specialist Medical Clinic, Tarnów, Poland.
- Parexel International, Paris, France.
ORCID-Profile: Philippe Bareille, Varsha Imber
Förderung
- GSK
Zitieren
APA
Bareille, P., Imber, V., Crawford, J., Majorek-Olechowska, B., Karam-Absi, Z., Stone, S., & Birk, R. (2023). A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26679
Vancouver
Bareille P, Imber V, Crawford J, Majorek-Olechowska B, Karam-Absi Z, Stone S, et al. A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26679
BibTeX
@article{Bareille2023,
author = {Bareille, Philippe and Imber, Varsha and Crawford, Jodie and Majorek-Olechowska, Bernadetta and Karam-Absi, Zeina and Stone, Sally and Birk, Ruby},
title = {A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26679}
}
EUVIMED